-
Abstract Number: 2411
Attainment of Complete Renal Response in Patients with Active Lupus Nephritis: A Multi-Center Cohort Study
-
Abstract Number: 2412
Validation of Proposals for Definitions of Moderate and Severe Disease Activity in Systemic Lupus Erythematosus, Based on Data Gathered from the RELESSER-PROS Register Database
-
Abstract Number: 2413
The Natural History of SLE Has Changed Since the 1970s
-
Abstract Number: 2414
A Retrospective Comparative Analysis of Cardiovascular Risk Factors, Atherosclerotic Cardiovascular Disease and Statin Use as Secondary Prevention in a Cohort of Patients with Systemic Lupus Erythematosus versus Without Rheumatological Disease from a Single-Center Patient Registry
-
Abstract Number: 2415
Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network
-
Abstract Number: 2416
The Impact of Active Lupus Nephritis on Work Productivity in Patients from a Latin American Lupus Cohort
-
Abstract Number: 2417
Frequency and Associated Factors of Herpes Zoster Infection in Systemic Lupus Erythematosus Patients from Latin-America
-
Abstract Number: 2418
Identification of Co-expressed Molecular Markers That Predict Risk of Severe Flare in Patients with Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 2419
Clinical and Patient-reported Outcomes in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS) US Data
-
Abstract Number: 2420
Blood Transcriptome Analysis Reveals Enhanced B Cell and Complement Cascade Signatures in Patients with Major Neuropsychiatric Systemic Lupus Erythematosus
-
Abstract Number: 2421
Trends in Glucocorticoid Use in Systemic Lupus Erythematosus in a Population-Based Inception Cohort from 1976 to 2018: The Lupus Midwest Network
-
Abstract Number: 2422
Development of a Multiplexed-engineered, Off-the-shelf CAR NK Cell with Unique Multi-Pathogenic Cell Targeting Capacity for the Treatment of Autoimmune Diseases in the Absence of Conditioning Chemotherapy
-
Abstract Number: 2423
Associations Between Cytometric Interferon Signature and Clinical Response in a Cohort of Anifrolumab-treated Patients with Lupus
-
Abstract Number: 2424
Anifrolumab Effects on Response to Influenza Vaccine in SLE
-
Abstract Number: 2425
Ianalumab Induced Durable Depletion of Circulating B Cell Subsets and Associated Changes in B Cell and Neutrophil Transcriptomic and Proteomic Profiles in Patients with Systemic Lupus Erythematosus: 52-Week Treatment Results from a Phase 2 Trial
- « Previous Page
- 1
- …
- 162
- 163
- 164
- 165
- 166
- …
- 182
- Next Page »